What we need to do is get the price down of cancer drug development. The fundamental problem is cancer is really many diseases so that any targeted drug will on

What we need to do is get the price down of cancer drug development. The fundamental problem is cancer is really many diseases so that any targeted drug will only be specific for a very small subset of cancers. This means the market for any new targeted drug is very small and so the ludicrous cost of bring as new drug to market is too great to be supported by the small number of people that will use it. The cost of these new targeted drugs is basically too high for any healthcare system to support, but the we need to make the drugs even more specific if we are going to get all the cancer types. Smaller and smaller market with every rising development costs = failure.